Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
3.720
+0.161 (4.53%)
At close: Jun 18, 2025, 4:00 PM
3.730
+0.010 (0.26%)
After-hours: Jun 18, 2025, 5:04 PM EDT
Burning Rock Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Revenue | 523.28 | 515.82 | 537.44 | 563.24 | 507.86 | 429.9 | Upgrade
|
| Revenue Growth (YoY) | 0.53% | -4.02% | -4.58% | 10.90% | 18.13% | 12.63% | Upgrade
|
| Cost of Revenue | 149.17 | 153.42 | 174.21 | 183.2 | 143.72 | 115.98 | Upgrade
|
| Gross Profit | 374.11 | 362.4 | 363.23 | 380.04 | 364.15 | 313.92 | Upgrade
|
| Selling, General & Admin | 379.2 | 452.54 | 685.53 | 938.58 | 793.35 | 462.39 | Upgrade
|
| Research & Development | 206.69 | 232.29 | 347.02 | 421.87 | 367.86 | 263.94 | Upgrade
|
| Operating Expenses | 585.89 | 684.83 | 1,033 | 1,360 | 1,161 | 726.33 | Upgrade
|
| Operating Income | -211.78 | -322.43 | -669.32 | -980.41 | -797.06 | -412.41 | Upgrade
|
| Interest Expense | - | - | - | - | -1.54 | -0.67 | Upgrade
|
| Interest & Investment Income | 10.76 | 12.21 | 17.96 | 9.36 | 3.46 | 6.07 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.11 | -0.1 | -0.42 | 1.55 | -0.85 | -2.85 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.62 | 4.71 | 0.48 | 0.25 | 0.2 | 2.62 | Upgrade
|
| EBT Excluding Unusual Items | -197.52 | -305.61 | -651.3 | -969.25 | -795.8 | -407.24 | Upgrade
|
| Asset Writedown | -35.13 | -35.13 | - | - | - | - | Upgrade
|
| Pretax Income | -232.65 | -340.74 | -651.3 | -969.25 | -795.8 | -407.24 | Upgrade
|
| Income Tax Expense | 5.93 | 5.89 | 2.39 | 1.99 | 0.9 | - | Upgrade
|
| Net Income | -238.58 | -346.63 | -653.69 | -971.23 | -796.7 | -407.24 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 64.69 | Upgrade
|
| Net Income to Common | -238.58 | -346.63 | -653.69 | -971.23 | -796.7 | -471.92 | Upgrade
|
| Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 7 | Upgrade
|
| Shares Change (YoY) | 1.73% | 0.53% | -1.46% | -0.29% | 51.83% | 192.26% | Upgrade
|
| EPS (Basic) | -22.90 | -33.67 | -63.84 | -93.47 | -76.45 | -68.76 | Upgrade
|
| EPS (Diluted) | -22.90 | -33.67 | -63.84 | -93.47 | -76.45 | -68.76 | Upgrade
|
| Free Cash Flow | -81 | -97.68 | -263.89 | -527.1 | -688.81 | -149.12 | Upgrade
|
| Free Cash Flow Per Share | -7.77 | -9.49 | -25.77 | -50.73 | -66.10 | -21.73 | Upgrade
|
| Gross Margin | 71.49% | 70.26% | 67.58% | 67.47% | 71.70% | 73.02% | Upgrade
|
| Operating Margin | -40.47% | -62.51% | -124.54% | -174.07% | -156.94% | -95.93% | Upgrade
|
| Profit Margin | -45.59% | -67.20% | -121.63% | -172.44% | -156.87% | -109.77% | Upgrade
|
| Free Cash Flow Margin | -15.48% | -18.94% | -49.10% | -93.58% | -135.63% | -34.69% | Upgrade
|
| EBITDA | -180.41 | -271.05 | -537.87 | -859.66 | -752.46 | -379.95 | Upgrade
|
| EBITDA Margin | -34.48% | -52.55% | -100.08% | -152.63% | -148.16% | -88.38% | Upgrade
|
| D&A For EBITDA | 31.37 | 51.39 | 131.45 | 120.75 | 44.6 | 32.46 | Upgrade
|
| EBIT | -211.78 | -322.43 | -669.32 | -980.41 | -797.06 | -412.41 | Upgrade
|
| EBIT Margin | -40.47% | -62.51% | -124.54% | -174.07% | -156.94% | -95.93% | Upgrade
|
| Revenue as Reported | 515.82 | 515.82 | 537.44 | 563.24 | 507.86 | 429.9 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.